Long-Term Economic and Clinical Value of Minimally Invasive SIJ Fusion for Refractory Sacroiliac Joint Pain

Friday, November 14, 2025

10:38 AM - 10:46 AM CT

Location: 301 - 302

Introduction: Chronic sacroiliac joint (SIJ) dysfunction contributes to up to 30% of axial low back pain cases, and standard conservative therapies often yield only temporary relief. Given the shift toward value-based healthcare, durable interventions that improve quality of life while reducing opioid reliance and healthcare utilization are increasingly important. Minimally invasive SIJ fusion (MI-SIJF), utilizing triangular titanium implants, has emerged as an effective, evidence-based solution for patients with refractory SIJ pain.¹⁻⁴

Submitting Author(s)

ER

Edgar Remotti, MD

Physician
CNY Brain and Spine Neurosurgery
Rochester, New York, United States

Co-Author(s)

RF

Ruby Feng, MD

Resident
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

WS

Wahab Stephanie, MD

Fellow
Northwestern, United States

Presenting Author(s)

SN

Savio Nogueira, MD

Resident
BIDMC/Harvard, United States

Co-Author(s)

MG

Meredith Galvin, MD

Resident
BIDMC/Harvard, United States

EM

Elishama Michel, MD

Resident
BIDMC/Harvard, United States

AB

Amit Beniwal, MD

Resident
BIDMC/Harvard, United States

SA

Sahil Amin, MD

Resident
BIDMC/Harvard, United States

PV

Peter Vu, MD

Fellow
BIDMC/Harvard, United States

CR

Colton Reeh, MD

Fellow
BIDMC/Harvard, United States